VERALTO CORPORATION (VLTO) Spending and interest coverage
- R&D / revenue · 12 months: Value 4.83%; Formula and calculation Research and development expense / revenue. Period ending 2026-04-03..
- Stock-based compensation / revenue · 12 months: Value 1.32%; Formula and calculation Share-based compensation / revenue. Period ending 2026-04-03..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-04-03; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 4.83% | Research and development expense / revenue. Period ending 2026-04-03. $270.00M ÷ $5.59B × 100 ≈ 4.83% |
| Stock-based compensation / revenue · 12 months | 1.32% | Share-based compensation / revenue. Period ending 2026-04-03. $74.00M ÷ $5.59B × 100 ≈ 1.32% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 270.00M USD | Research and Development Expense |
| Revenue | 5.59B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 74.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 1.29B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-03 | $270.00M | $5.59B | $74.00M | $1.29B | (m) | 4.83% | 1.32% | (m) | (m) |
| 2025-12-31 | $266.00M | $5.50B | $74.00M | $1.28B | (m) | 4.83% | 1.34% | (m) | (m) |
| 2025-10-03 | $267.00M | $5.45B | $74.00M | $1.27B | (m) | 4.90% | 1.36% | (m) | (m) |
| 2025-07-04 | $263.00M | $5.36B | $70.00M | $1.25B | (m) | 4.90% | 1.31% | (m) | (m) |
| 2025-04-04 | $257.00M | $5.28B | $66.00M | $1.24B | (m) | 4.87% | 1.25% | (m) | (m) |
| 2024-12-31 | $253.00M | $5.19B | $65.00M | $1.21B | (m) | 4.87% | 1.25% | (m) | (m) |
| 2024-09-27 | $241.00M | $5.14B | $72.00M | $1.19B | (m) | 4.69% | 1.40% | (m) | (m) |
| 2024-06-28 | $233.00M | $5.08B | $68.00M | $1.15B | $88.00M | 4.59% | 1.34% | 13.08× | Reported |
| 2024-03-29 | $229.00M | $5.04B | $61.00M | $1.14B | $58.00M | 4.54% | 1.21% | 19.67× | Reported |
| 2023-12-31 | $225.00M | $5.02B | $55.00M | $1.14B | $30.00M | 4.48% | 1.10% | 38.00× | Reported |
| 2023-09-29 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $217.00M | $4.87B | $41.00M | $1.11B | $0.00 | 4.46% | 0.84% | (m) | Reported |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $244.00M | $4.70B | $34.00M | $1.04B | $0.00 | 5.19% | 0.72% | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ITRON, INC. (ITRI) | United States | $4.008B | 13.83 |
| AEHR TEST SYSTEMS (AEHR) | United States | $3.176B | -420.65 |
| COHU INC (COHU) | United States | $3.015B | -82.78 |
| ALLIENT INC (ALNT) | United States | $1.913B | 61.10 |
| FREQUENCY ELECTRONICS INC (FEIM) | United States | $0.952B | 236.51 |
| TRANSCAT INC (TRNS) | United States | $0.805B | 250.33 |
| INTEST CORP (INTT) | United States | $0.146B | 291.94 |
| ScanTech AI Systems Inc. (STAI) | United States | $0.069B | -2.69 |
| DATA I/O CORP (DAIO) | United States | $0.030B | -4.65 |
| TERADYNE, INC (TER) | United States | $60.595B | 59.25 |